Purchases and Sales Made in Q3 2023 in Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC) during Q3 2023. The information is specifically focused on institutions that hold shares of Oric Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-4.25K- 13.71% |
$25.7K - $39.5K
|
26.8K
$228K
|
|
|
Nov 14, 2023
Q3 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-4.37K- 33.67% |
$26.5K - $40.6K
|
8.61K
$73.2K
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-5K- 22.44% |
$30.2K - $46.4K
|
17.3K
$147K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-5.17K- 31.38% |
$31.3K - $48K
|
11.3K
$96.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-8.01K- 14.27% |
$48.5K - $74.4K
|
48.2K
$409K
|
|
|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-10K- 2.77% |
$60.5K - $92.8K
|
352K
$2.99M
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
- |
-11.6K- 99.78% |
$70.2K - $108K
|
25
$213
|
|
|
Nov 14, 2023
Q3 2023
|
Atom Investors LP
Austin, TX |
SELL
|
- |
-11.7K- 25.4% |
$70.5K - $108K
|
34.2K
$291K
|
|
|
Nov 06, 2023
Q3 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-12.2K- 8.89% |
$73.7K - $113K
|
125K
$1.06M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-14.6K- 1.99% |
$88.3K - $135K
|
719K
$6.11M
|
|
|
Nov 14, 2023
Q3 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-17.9K- 28.46% |
$109K - $167K
|
45.1K
$383K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-24.4K- 16.42% |
$148K - $226K
|
124K
$1.06M
|
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-52.5K- 66.46% |
$318K - $487K
|
26.5K
$225K
|
|
|
Nov 14, 2023
Q3 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-56.5K- 53.71% |
$342K - $524K
|
48.7K
$414K
|
|
|
Nov 13, 2023
Q3 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-62.2K- 15.41% |
$377K - $578K
|
342K
$2.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-75.5K- 70.82% |
$457K - $701K
|
31.1K
$264K
|
|
|
Nov 15, 2023
Q3 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-85.5K- 71.53% |
$517K - $793K
|
34K
$289K
|
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-146K- 32.16% |
$882K - $1.35M
|
307K
$2.61M
|
|
|
Nov 13, 2023
Q3 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-148K- 86.69% |
$894K - $1.37M
|
22.7K
$193K
|
|
|
Nov 14, 2023
Q3 2023
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-182K- 6.58% |
$1.1M - $1.69M
|
2.58M
$21.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-275K- 23.52% |
$1.66M - $2.55M
|
894K
$7.6M
|
|
|
Nov 13, 2023
Q3 2023
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-327K- 22.57% |
$1.98M - $3.04M
|
1.12M
$9.55M
|